 Qiagen NV NYSE: QGEN has reported higher-than-expected second-quarter interim earnings but lowered its outlook on weaker demand for COVID-19 tests, sending its shares lower. The company expects Q2 adjusted EPS of 0.65-0.66 on a constant exchange rate CER versus the outlook for about 0.62-0.64 CER. 